Harnessing basic electrical, chemical, and bioengineering advances to treat arrhythmias
HOUSTON – (August 17, 2017) Dr. Razavi and his team are harnessing basic electrical, chemical, and bioengineering advances in preclinical models to develop the next generation of treatments for the management and prevention of deadly cardiac arrhythmias. EP Digest highlights new developments in the Texas Heart Institute Electrophysiology Clinical Research & Innovations Lab.
Payam Safavi-Naeini, MD, Brian D. Greet, MD, David Burkland, MD, Mathews M. John, MEng, Anand V. Ganapathy, MBE, Abdi Rasekh, MD, Mohammad Saeed, MD, Joanna Esther Molina Razavi, MD, Mehdi Razavi, MD. From the Mercury Capillary Electrometer to the Wireless, Battery-Less Pacemaker: State-of-the-Art Innovations in the Treatment of Arrhythmia; Issue Number Volume 17 – Issue 8 – August 2017. Department of Cardiology, Texas Heart Institute, Houston, Texas; Department of Internal Medicine, Section of Cardiology, Baylor College of Medicine, Houston, Texas.